SLC3A2 and cancer: Here, we show that d-Cys selectively impairs proliferation of those cancer cell lines that exhibit high expression of the cystine/glutamate antiporter xCT/CD98, while sparing cells with low levels of xCT/CD98 and cystine uptake.